[Effects of immunopotentiator on six patients with HBeAg positive chronic hepatitis (author's transl)].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D002908:Chronic Disease; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000628:therapy*; D006511:Hepatitis B Antigens / Q000276:immunology*; D006513:Hepatitis B e Antigens / Q000276:immunology*; D006801:Humans; D008297:Male; D010844:Picibanil / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D001688:Biological Products; D006511:Hepatitis B Antigens; D006513:Hepatitis B e Antigens; D010844:Picibanil